BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15816613)

  • 1. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2003; 23(6D):5015-22. PubMed ID: 14981961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Fas and Fas ligand expressions in human esophageal cancer.
    Shibakita M; Tachibana M; Dhar DK; Kotoh T; Kinugasa S; Kubota H; Masunaga R; Nagasue N
    Clin Cancer Res; 1999 Sep; 5(9):2464-9. PubMed ID: 10499620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
    Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer.
    Ohno S; Ohno Y; Suzuki N; Kamei T; Koike K; Inagawa H; Kohchi C; Soma G; Inoue M
    Anticancer Res; 2004; 24(5C):3335-42. PubMed ID: 15515429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas ligand expression in metastatic renal cell carcinoma during interleukin-2 based immunotherapy: no in vivo effect of Fas ligand tumor counterattack.
    Donskov F; von der Maase H; Marcussen N; Hamilton-Dutoit S; Madsen HH; Jensen JJ; Hokland M
    Clin Cancer Res; 2004 Dec; 10(23):7911-6. PubMed ID: 15585624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Fas expression is related to increased apoptosis of circulating CD8+ T cell in patients with gastric cancer.
    Yoshikawa T; Saito H; Osaki T; Matsumoto S; Tsujitani S; Ikeguchi M
    J Surg Res; 2008 Aug; 148(2):143-51. PubMed ID: 18561948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma.
    Ohno S; Tachibana M; Fujii T; Ueda S; Kubota H; Nagasue N
    Int J Cancer; 2002 Feb; 97(6):770-4. PubMed ID: 11857352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Tn and sialyl-Tn antigens in endometrial cancer: its relationship with tumor-produced cyclooxygenase-2, tumor-infiltrated lymphocytes and patient prognosis.
    Ohno S; Ohno Y; Nakada H; Suzuki N; Soma G; Inoue M
    Anticancer Res; 2006; 26(6A):4047-53. PubMed ID: 17195456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands.
    Shieh YS; Hung YJ; Hsieh CB; Chen JS; Chou KC; Liu SY
    Ann Surg Oncol; 2009 Mar; 16(3):751-60. PubMed ID: 19116756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
    Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
    Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
    Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
    Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
    Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC; Barnetson RS; Halliday GM
    Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression.
    Prado-Garcia H; Aguilar-Cazares D; Meneses-Flores M; Morales-Fuentes J; Lopez-Gonzalez JS
    Cancer Immunol Immunother; 2008 Mar; 57(3):325-36. PubMed ID: 17668204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.